Acquisition Of Tissue-assessment TechnologyAcquisition of a company developing integrated robotics and AI for biopsy tissue assessment can broaden the surgical robotics portfolio and enable applications across lung, liver, pancreas, breast and lymph node procedures, expanding the addressable market.
Advanced Dye-free Imaging PipelineDevelopment of dye-free hyperspectral tissue oxygenation imaging that provides quantitative oxygenation maps could reduce subjective interpretation, improve decision-making in surgery and complement existing imaging techniques to enhance outcomes.
New-generation Surgical Robot And Fleet ExpansionIntroduction of a new-generation surgical robot can trigger system upgrades, fleet expansion and deployment of refurbished units, enabling more hospitals to adopt minimally invasive and complex surgeries and supporting procedure volume growth.